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Shiga toxin (Stxs) is a family of structurally and functionally related bacterial cytotoxins
produced by Shigella dysenteriae serotype 1 and shigatoxigenic group of Escherichia
coli that cause shigellosis and hemorrhagic colitis, respectively. Until recently, it has
been thought that Stxs only inhibits the protein synthesis and induces expression to
a limited number of genes in host cells, but recent data showed that Stxs can trigger
several signaling pathways in mammalian cells and activate cell cycle and apoptosis.
To explore the changes in gene expression induced by Stxs that have been shown
in other systems to correlate with cancer progression, we performed the simulated
analysis of cDNA dataset and found differentially expressed genes (DEGs) of human
THP1-monocytic cells treated with Stxs. In this study, the entire data (treated and
untreated replicates) was analyzed by statistical algorithms implemented in Bioconductor
packages. The output data was validated by the k-fold cross technique using generalized
linear Gaussian models. A total of 50 DEGs were identified. 7 genes including TSLP, IL6,
GBP1, CD274, TNFSF13B, OASL, and PNPLA3were considerably (<0.00005) related to
cancer proliferation. The functional enrichment analysis showed 6 down-regulated and
1 up-regulated genes. Among these DEGs, IL6 was associated with several cancers,
especially with leukemia, lymphoma, lungs, liver and breast cancers. The predicted
regulatory motifs of these genes include conserved RELA, STATI, IRFI, NF-kappaB,
PEND, HLF, REL, CEBPA, DI_2, and NFKB1 transcription factor binding sites (TFBS)
involved in the complex biological functions. Thus, our findings suggest that Stxs has the
potential as a valuable tool for better understanding of treatment strategies for several
cancers.
Keywords: cDNA dataset, Shiga toxin, differential expression, cancers, enrichment analysis, TFBS
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INTRODUCTION
Shiga toxins (Stxs) are bacterial cytotoxins mainly produced
by enteric pathogens. It is a family of related toxins with two
major groups, Stx1 and Stx2, encoded by genes belonging to
the lambdoid prophages genome (Friedman and Court, 2001).
The sources of Stxs includes Shigella dysenteriae, the Shiga
toxigenic group of Escherichia coli (STEC) including serotypes
O157:H7, O104:H4, and other enterohemorrhagic E. coli (EHEC)
(Beutin, 2006; Spears et al., 2006) responsible for millions of cases
of severe dysentery, food poisoning, gastroenteritis and bowel
necrosis (Mims et al., 1993; Vogt and Dippold, 2005; Todar, 2007;
World Health Organization, 2016), and this situation is worse in
underdeveloped countries.
The Stxs are capable to cross epithelial, endothelial, leukocytic,
lymphoid and other neuronal cells through transcytotic or
paracellular mechanisms (Malyukova et al., 2009), may then
associate with blood monocytes, macrophages and neutrophils
to circulate the bloodstream and bind to toxin-binding
glycosphingolipid Gb3 receptor by clathrin-dependent or
clathrin-independent mechanisms (Lingwood, 2003; Schweppe
et al., 2008). After internalization, the toxins undergo retrograde
intracellular flow to reach the endoplasmic reticulum (Sandvig
et al., 2002). Importantly, the toxin receptor, Gb3, has a limited
expression in normal tissues but is overexpressed in several types
of cancer and besides apoptosis, may cause “apoptosis induced
proliferation” (Torgersen et al., 2010). Stxs are cytotoxic proteins
that enter the host cell via macropinosome and function as an
N-glycosidase, cleave a specific adenine nucleobase from the 28S
RNA of the 60S subunit of the ribosome, thereby halting host
cell protein synthesis (Sandvig et al., 2010; Lukyanenko et al.,
2011). This activity of the toxin resides in the A subunit and the
pentamer of similar B subunit intercedes toxin binding to theGb3
(Fraser et al., 1994; Lingwood et al., 2010; Melton-Celsa, 2014).
These toxins can also activate host cell’s signaling pathways and
trigger apoptosis in many cell types. They induce apoptosis of
epithelial, endothelial, leukocytic, lymphoid and neuronal cells
(Tesh, 2010). After activation, the interleukin-1 (IL-1) and tumor
necrosis factor alpha (TNF-α) sensitize endothelial cells to the
action of Stx in vitro by increasing Gb3 expression (van de
Kar et al., 1992; Stricklett et al., 2002). Upon sensitization, the
innate immune response stimulated by Stxs may contribute to
the development of vascular lesions (Ramegowda et al., 1999).
It has been reported that when human monocytic THP-1 cells
are treated with Stxs, they secrete tumor necrosis factor alpha
(TNF-α)-, interleukin-1 (IL-1), and interleukin-6 (IL-6), which
further alter the expression of these cytokines and chemokines
(Leyva-Illades et al., 2010). Transcriptional regulation involves
prolonged activation of stress-associated protein kinases JNK (c-
Jun N-terminal kinases) and p38, extracellular signal-activated
kinase1/2 (ERK1/2), and activation of transcription factors NF-
kappaB (NF-κB) (nuclear factor) (Thorpe et al., 2001; Harrison
et al., 2005). Recent evidence indicates that signaling through
MAPK pathways and proapoptotic proteins -mostly caspases-
can induce proliferation of neighboring surviving cells to replace
apoptotic and dying cells. This “apoptosis induced proliferation”
is critical for tissues regeneration and cancer progression (Tesh,
2010; Ryoo and Bergmann, 2012).
The expression profiling of treated and untreated THP-1
cells verifies that Stxs are responsible for genetic alterations
(Leyva-Illades et al., 2010). Studies show that Stxs is associated
with an elevated secretion of cytokines and other chemical
mediators responsible for numerous diseases including cancer
(DesRochers et al., 2015; Hattori et al., 2016). E. coli producing
Stxs was isolated from cancer and diarrheagenic individuals
(Chao et al., 2017). It has been observed that Stxs significantly
caused increased expression of GRO, G-CSF, IL-1β, IL-8, and
TNFα in THP-1 like cells with an increased level of pro-
inflammatory cytokines and chemokines causing several diseases
(Brandelli et al., 2015). The exact mechanism of influence of gene
expression by Stxs as well as the functions of these influenced
genes in respect to pathophysiology and molecular biology
of cancer development have not been completely understood
(Tesh, 2010). In this regard, cDNA microarray technology
is a valuable tool to discover differential gene expression.
The accumulated data from gene expression studies in public
repositories provides an opportunity to construct pooled gene
expression data sets from a larger number of individuals.
In this study, we performed cDNA differential analysis of
the publicly available dataset to discover the DEGs and to
further explore the transcriptional responses of human THP1-
monocytic cells affected by bacterial Stxs. We uncovered the
aberrantly expressed genes which are significantly linked to
cancer. We also report the analysis of the pathophysiological
pathways and predicted potential regulatory motif of these
genes.
MATERIALS AND METHODS
Accession of cDNA Dataset
The goal of this study was to identify aberrantly expressed
cancer-related genes in the human THP1-monocytic cells lines
affected by bacterial Shiga toxins (Supplementary Figure 1).
We acquired the cDNA microarray dataset (NCBI, 2015)
GSE19315 (Leyva-Illades et al., 2010) from Gene Expression
Omnibus database (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE19315)1. This dataset examined the transcriptional
changes in human THP-1 cells to Stxs toxins. It was performed
by taking three untreated (controls) and six treated replicates
(samples) followed by the real-time studies. The Stxs changed
the genetic expression which is associated with the increased
production of cytokines and other proinflammatory mediators.
The GPL570 [HG-U133_Plus_2] Affymetrix Human Genome
U133 Plus 2.0 Array (Affymetrix, Inc., Santa Clara, CA, 95051,
USA, Technology: in situ oligonucleotide) platformwas used, and
the Annotation information (hgu133plus2) of probes was used to
detect the gene expression.
Normalization and Identification of
Differentially Expressed Genes (DEGs)
Pheno-data files of this dataset were prepared in identifiable
format and missing values imputed (Troyanskaya et al., 2001).
The Bioconductor packages including ArrayQuality Metrics on
1Gene Expression Omnibus: http://www.ncbi.nlm.nih.gov/geo/. Accessed 2016-
05.25.
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FIGURE 1 | Normalization and analysis of array quality metrics (A) Box-plot representing summaries of the signal intensity distributions of the arrays. Each box
corresponds to one array. Outlier detection was performed by computing the Kolmogorov-Smirnov statistic Ka between each array’s distribution and the distribution
of the pooled data (B) Heatmap of the distances between arrays. The color scale is chosen to cover the range of distances encountered in the dataset (C) Histogram
representing expression after normalization (D) MA plots. M and A are defined as: M = log2(I1) – log2(I2), A = 1/2 (log2(I1)+log2(I2)), where I1 is the intensity of the
array studied, and I2 is the intensity of a “pseudo”-array that consists of the median across arrays.
FIGURE 2 | Side-by-side plot produced by plotAffyRNAdeg representing 5
′
-3
′
trend to assess the severity of degradation of RNA and significance level.
TABLE 1 | A summary statistic for each array in the batch, assessing the severity
of RNA degradation and significance level.
S. no Arrays/Samples Slope P-value
1 GSM479983.CEL 1.01000 0.00109
2 GSM479984.CEL 1.000000 0.000827
3 GSM479985.CEL 1.41e+00 1.15e-05
4 GSM479986.CEL 0.6570 0.0183
5 GSM479987.CEL 1.18000 0.00033
6 GSM479988.CEL 1.10e+00 9.65e-05
7 GSM479989.CEL 0.91700 0.00196
8 GSM479990.CEL 0.97500 0.00112
9 GSM479991.CEL 1.40e+00 1.32e-05
R version 3.1.3 were used to execute the preprocessing steps of
normalization and quality control (Bolstad et al., 2003; Fujita
et al., 2006; Obenchain et al., 2014). Robust Multi-array Analysis
(RMA) was used to adjust the background and normalization
(Yoon et al., 2004) for perfect matches (PM) and mismatches
(MM) in order to get a summary of intensities (summary
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TABLE 2 | List of 50-differentially expressed genes.
S. no Probe ID Gene ID logFC t P-value adj.P.Val B Aberration
1 240287_at irg1 −5.93568 −50.392 7.88E-12 2.30E-07 14.35412 Down-regulated
2 235737_at TSLP −5.81414 −50.0105 8.41E-12 2.30E-07 14.33257
3 235574_at GBP4 −4.36184 −40.5895 4.93E-11 8.98E-07 13.64744
4 205207_at IL6 −5.18603 −37.197 1.03E-10 1.41E-06 13.30453
5 202510_s_at TNFAIP2 −4.1804 −34.7333 1.84E-10 2.01E-06 13.01096
6 202269_x_at GBP1 −3.20432 −33.4148 2.55E-10 2.32E-06 12.83562
7 227458_at CD274 −5.57009 −31.9417 3.73E-10 2.91E-06 12.62265
8 223501_at TNFSF13B −4.88682 −31.3969 4.31E-10 2.95E-06 12.53892
9 210797_s_at OASL −4.56379 −29.9747 6.38E-10 3.87E-06 12.3066
10 214038_at ccl8 −6.57392 −28.3084 1.03E-09 5.65E-06 12.00654
11 205013_s_at Adora2a −3.81754 −27.4662 1.33E-09 6.62E-06 11.84223
12 205569_at LAMP3 −6.29062 −26.5359 1.78E-09 8.03E-06 11.64986
13 229450_at Ifit3 −4.28387 −26.3161 1.91E-09 8.03E-06 11.60267
14 222793_at DDX58 −4.25905 −25.5566 2.44E-09 8.71E-06 11.43411
15 218810_at ZC3H12A −2.84809 −25.299 2.66E-09 8.71E-06 11.37495
16 205660_at OASL −4.97761 −25.0953 2.84E-09 8.71E-06 11.32745
17 202688_at TNFSF10 −5.15206 −25.0718 2.87E-09 8.71E-06 11.32192
18 205599_at Traf1 −4.14304 −24.8005 3.14E-09 8.87E-06 11.2575
19 204747_at Ifit3 −4.25172 −24.7046 3.25E-09 8.87E-06 11.23446
20 219716_at APOL6 −2.70983 −24.2599 3.78E-09 9.53E-06 11.12554
21 202759_s_at akap2/PALM2 −2.47769 −24.2173 3.84E-09 9.53E-06 11.11493
22 230036_at SAMD9L −2.94113 −22.691 6.62E-09 1.57E-05 10.71328
23 235643_at SAMD9L −3.19263 −22.0591 8.39E-09 1.84E-05 10.53392
24 223502_s_at TNFSF13B −5.13985 −21.8857 8.96E-09 1.84E-05 10.48325
25 205992_s_at IL15 −4.10568 −21.8596 9.05E-09 1.84E-05 10.47556
26 209038_s_at EHD1 −3.57268 −21.8496 9.09E-09 1.84E-05 10.47261
27 209037_s_at EHD1 −4.10382 −21.4847 1.05E-08 2.04E-05 10.36366
28 242752_at – −2.33834 −21.2349 1.15E-08 2.08E-05 10.28736
29 226757_at Ifit2 −5.22852 −21.224 1.16E-08 2.08E-05 10.28402
30 231577_s_at GBP1 −2.98548 −21.1802 1.18E-08 2.08E-05 10.27046
31 206157_at Ptx3 −3.72465 −20.8941 1.32E-08 2.19E-05 10.18102
32 208012_x_at SP110 −2.34041 −20.8471 1.35E-08 2.19E-05 10.16617
33 202760_s_at akap2/PALM2 −3.0481 −20.8187 1.36E-08 2.19E-05 10.15714
34 218943_s_at DDX58 −4.97703 −20.6726 1.44E-08 2.25E-05 10.11048
35 202086_at mx1 −3.63011 −19.9264 1.96E-08 2.98E-05 9.864092
36 225344_at NCOA7 −2.6496 −19.8461 2.03E-08 3.00E-05 9.836755
37 215495_s_at samd4a −1.78695 −19.4961 2.35E-08 3.39E-05 9.715643
38 220104_at ZC3HAV1 −3.4764 −19.3094 2.55E-08 3.57E-05 9.649722
39 210029_at IDO1 −6.46305 −19.2265 2.64E-08 3.61E-05 9.620158
40 211122_s_at CXCL11 −7.63526 −19.0851 2.81E-08 3.75E-05 9.569288
41 1557905_s_at CD44 −2.72423 −18.8999 3.05E-08 3.88E-05 9.501801
42 1555464_at IFIH1 −4.11661 −18.8975 3.05E-08 3.88E-05 9.500928
43 229221_at CD44 −3.80452 −18.6478 3.41E-08 4.16E-05 9.408394
44 210163_at CXCL11 −6.82817 −18.6392 3.42E-08 4.16E-05 9.405188
45 209723_at SERPINB9 −4.33364 −18.5564 3.55E-08 4.22E-05 9.37409
46 204103_at CCL4 −4.92524 −18.3405 3.91E-08 4.55E-05 9.292083
47 214329_x_at TNFSF10 −5.31551 −18.2625 4.05E-08 4.57E-05 9.262101
48 203915_at Cxcl9 −4.43103 −18.2429 4.09E-08 4.57E-05 9.254554
49 210285_x_at WTAP −2.59583 −18.1602 4.25E-08 4.65E-05 9.22254
50 220675_s_at pnpla3 2.423905 25.63874 2.38E-09 8.71E-06 11.45275 Up-regulated
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statistic). To assess the quality of RNA in samples, AffyRNAdeg,
summaryAffyRNAdeg, and plotAffyRNAdeg Bioconductor
packages were used for degradation analysis (Affymetrix, 1999,
2001). After normalization, we performed the relative study and
identified differentially expressed genes by pairwise comparison
from genomic experiments (Tusher et al., 2001) and multiple
testing corrections were completed by Benjamini-Hochberg
method (Benjamini and Hochberg, 1995). The Bioconductor
package LIMMA, a modified statistic that is proportional to the
statistic with sample variance offsets, was used to shortlist the
DEGs. By this package, duplicate spots and quality weights were
TABLE 3 | k-fold cross validation by bioconductor “boot” package using
dispersion parameter of Gaussian family.
Estimate Std. Error t-value Pr(>|t|)
(Intercept) 0.023823 0.003194 7.46* 8.81E−14***
x1 0.349441 0.00554 63.071 <2.00E−16***
x2 0.078029 0.00486 16.056 <2.00E−16***
x3 0.150248 0.002554 58.83 <2.00E−16***
x4 −0.09253 0.00321 −28.827 <2.00E−16***
x5 −0.00143 0.002231 −0.639** 0.523*
x6 0.773287 0.002425 318.819 <2.00E−16***
x7 −0.22529 0.005723 −39.362 <2.00E−16***
x8 −0.03568 0.00451 −7.91 <2.62E−15***
Deviance Residuals: Min (−3.1894), 1Q (−0.0996), Median (0.0004), 3Q (0.1016), Max
(1.2137).
Signif. codes: 0 “***” 0.001 “**” 0.01 “*” 0.05 “.” 0.1 “ ” 1.
Number of Fisher Scoring iterations: 2.
Null deviance: 195495.4 on 54674 degrees of freedom.
Residual deviance: 1786.6 on 54666 degrees of freedom.
measured. The moderated statistics were calculated; genes were
ranked with respect to the resulting scores and p-values. A false
discovery rate (FDR) less than 0.05, p≤ 0.05, Average Expression
Level (AEL) ≥40% and an absolute log fold change (logFC)
greater than 1 were set as the significant cutoffs.
K-Fold Cross Validation
We used the k-fold technique (Seymour, 1993) to validate the
shortlisted differentially expressed genes using the Bioconductor
“boot” package (Ripley, 2010). Bootstrapping can be helpful
to correct some of the bias associated with the analysis.
The generalized linear models (Gaussian) were applied and
the “cv.glm” function was used to assess the k-fold cross
validation for these cases. This function, firstly, predicts the
error of the raw cross-validation followed by the adjusted
cross validation estimation. The Gaussian function was trailed
by the complete Leave-One-Out-Cross-Validation (LOOCV)
procedure. The LOOCV method is instinctively named as one
case is left out as the testing set and the rest of the data are used
as the training set (Ripley, 2010).
Curation of Cancer-Related Genes
From the shortlist of DEGs, cancer-associated genes were curated
from OMIM (Online Mendelian Inheritance in Man) database
(www.ncbi.nlm.nih.gov/omim)2 and Cancer GeneticsWeb
database (www.cancer-genetics.org)3 to filter the significant
cancer-related genes. The roles of sorted genes in cancer were
2NCBI: http://www.ncbi.nlm.nih.gov/omim. Accessed 2015-08.28.
3Cancer Genetics Web: http://www.cancer-genetics.org/index.htm. Accessed at
Thursday Sep 10, 2016.
TABLE 4 | The differentially expressed cancer-related genes curated from OMIM and Cancer Genetics. Web databases and their role has been referenced from PubMed.
S. no Probe ID Gene ID Uniprot_ID PubMed count Protein name Reference links
1 235737_at TSLP TSLP_HUMAN 68 Thymic stromal lymphopoietin http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CTSLP%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D
2 205207_at IL6 IL6_HUMAN 1067 Interleukin-6 http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CIL6%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D
3 202269_x_at GBP1 GBP1_HUMAN 26 Interferon-induced
guanylate-binding protein
http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CGBP1%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D
4 227458_at CD274 PD1L1_HUMAN 430 Programmed cell death-1 http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CCD274%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D
5 223501_at TNFSF13B TN13B_HUMAN 68 Tumor necrosis factor ligand
superfamily member 13B
http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9CTNFSF13B%E2%80%9D+and+
%E2%80%9CCancer%E2%80%9D
6 210797_s_at OASL OASL_HUMAN 12 2′-5′-oligoadenylate synthase http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9COASL%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D
7 220675_s_at pnpla3 PLPL3_HUMAN 27 Patatin-like phospholipase
domain-c
http://www.ncbi.nlm.nih.gov/pubmed/?term=
%E2%80%9Cpnpla3%E2%80%9D+and+%E2
%80%9CCancer%E2%80%9D
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FIGURE 3 | Cluster analysis of 7 cancer-related DEGs with Euclidean distance (Binning method: Quantile). Green corresponds to a small distance and Red to a large
distance. Lines indicate the boundaries of the clusters in the level of the tree. Dotted lines indicate down or up-regulated genes.
evaluated through reported experimental studies using PubMed4
database.
Cluster and Functional Enrichment
Analysis of DEGs
We performed the cluster analysis (Eisen et al., 1998) based
on expression values in each sample to verify the variations in
gene expression levels between untreated and treated replicates.
The functional Annotation and pathway enrichment analysis
of cancer-related genes help us to reveal biological functions
(Nam and Kim, 2008; Muhammad et al., 2015), and it
was performed using the web-based DAVID (Database for
Annotation Visualization and Integrated Discovery) (Huang da
et al., 2009) and FunRich Annotation tools (Pathan et al., 2015).
Construction of Protein-Protein Interaction
(PPI) Network
Proteins usually interact with each other to perform biological
functions (Li et al., 2004; Muhammad et al., 2014; Naz et al.,
4PubMed: http://www.ncbi.nlm.nih.gov/pubmed. Accessed 2015-08-28.
2015). Therefore, the interacting partners of cancer-related
genes were assessed with a high confidence score (0.999) from
the STRING (Search Tool for the Retrieval of Interacting
Genes/Proteins) (Szklarczyk et al., 2011) and HAPPI (Human
Annotated and Predicted Protein Interaction) databases (Chen
et al., 2009), and PPI-network were constructed using Cytoscape
software (Cline et al., 2007) version 3.2.1. STRING and HAPPI
connect major databases and predict interactions based on
experiments, text mining and sequence homology. The role and
association of these genes (source and target) in cancer were
accessed from OMIM (www.omim.org), Cancer Genetics Web
(www.cancerindex.org) and National Cancer Database (www.
facs.org)5. The relationships between source proteins and target
proteins (interacting proteins) were finally calculated.
De Novo Prediction of Regulatory Motifs
To better understand the complex mechanisms of cancer-
related, differentially expressed genes controlling important
biological functions at transcriptional and post-transcriptional
levels, oPOSSUM web tool (Ho Sui et al., 2005) was used to
5National Cancer Database: http://www.facs.org. Accessed 2016-01.01.
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TABLE 5 | Functional and GO* analysis of 7-differentially expressed genes.
S.no Term Count P-value Fold enrichment
1 [GO:0006955] immune response 6 1.68E-05 13.1
2 [GO:0042129] regulation of T cell proliferation 3 5.69E-04 72.7
3 [GO:0050670] regulation of lymphocyte proliferation 3 0.001017 54.3
4 [GO:0070663] regulation of leukocyte proliferation 3 0.001041 53.7
5 [GO:0032944] regulation of mononuclear cell proliferation 3 0.001041 53.7
6 [GO:0050863] regulation of T cell activation 3 0.002007 38.5
7 [GO:0051249] regulation of lymphocyte activation 3 0.003188 30.5
8 [GO:0002694] regulation of leukocyte activation 3 0.003992 27.2
9 [GO:0050865] regulation of cell activation 3 0.004426 25.8
10 [GO:0005125] cytokine activity 3 0.004485 25.0
11 [GO:0050871] positive regulation of B cell activation 2 0.019354 91.1
12 [GO:0001776] leukocyte homeostasis 2 0.021097 83.5
13 [GO:0042102] positive regulation of T cell proliferation 2 0.022838 77.1
14 [GO:0050864] regulation of B cell activation 2 0.029772 58.9
15 [GO:0050671] positive regulation of lymphocyte proliferation 2 0.032074 54.7
16 [GO:0032946] positive regulation of mononuclear cell proliferation 2 0.032649 53.7
17 [GO:0070665] positive regulation of leukocyte proliferation 2 0.032649 53.7
18 [GO:0050870] positive regulation of T cell activation 2 0.044081 39.6
19 [GO:0002237] response to molecule of bacterial origin 2 0.049753 35.0
20 [GO:0051251] positive regulation of lymphocyte activation 2 0.055958 31.0
21 [GO:0048872] homeostasis of number of cells 2 0.057644 30.1
22 [GO:0002696] positive regulation of leukocyte activation 2 0.061008 28.4
23 [GO:0050867] positive regulation of cell activation 2 0.063803 27.1
24 [GO:0042127] regulation of cell proliferation 3 0.074923 5.7
25 [GO:0002252] immune effector process 2 0.076569 22.4
*GO, Gene Ontology.
identify the transcription factor (TF) binding sites and over-
represented regulatory motif of target matrices (Pavesi et al.,
2004) in promoter regions of expressed genes using default
parameters.
RESULTS
Microarray Analysis, Normalization, and
RNA Degradation Plots
The microarray data consists of 9-samples with 54675 probe
ids from a study of the effect of bacterial Shiga toxins on
human THP1 macrophage/monocytic cell lines (Leyva-Illades
et al., 2010). The AffyBatch object comprises the size of the
array 1,164 × 1,164 features with 54,675 affyids. Background
correction and normalization by quantile normalization were
completed to avoid systematic variation between samples. The
normalized probe-level data represents expression levels of
genes of entire DNA chip (Figure 1) involved in experimental
condition and individual probes in a probe set were ordered by
location relative to the 5′ end of the targeted RNA molecule.
The 3′/5′ intensity gradient has been shown to depend on the
degree of competitive binding of specific and of non-specific
targets to a particular probe. Poor RNA quality is linked with
a reduced amount of RNA quantity hybridized to the array
paralleled by a declined total signal level. Increasing degrees
of saturation reduce the 3′/5′ intensity gradient. The probe set
contained the target gene at a position near the 3′ end of the
corresponding transcripts. A side-by-side plot was produced
by the function plotAffyRNAdeg (Figure 2), and the function
summary of AffyRNAdeg produced a single summary statistic
for each array in the batch (Table 1), presenting an assessment
of the severity of RNA-degradation and significance level. We
focused to sort out important factors in the cDNA dataset such
as sequences biases, RNA degradation and quality of RNA to
ensure the reliability of the dataset to identify transcriptional
variations of the original samples. We standardized the sample
handling procedures through normalization and assessed the
optimal RNA reliability threshold using statistical and algorithm
discrimination measures.
Identifying Differentially Expressed Genes
(DEGs)
Our analyses revealed a total of 50 DEGs from Shiga effected
human THP1-monocytic cells between 03 untreated and 06
treated to replicate samples, including 01 up-regulated (2%)
and 49 down-regulated (98%) DEGs (Table 2). For generalized
linear models, the “cv.glm” function estimated the k–fold
cross-validation prediction error. The dispersion parameter for
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Gaussian is 0.03268, which indicates the confidence models.
The similar delta value of 0.032715 with 10 K-folds estimation
is obtained when we used the LOOCV method (during raw
cross-validation and then during adjusted cross-validation). The
significant codes (0.1, 0.01, 0.001, and 0.05) with minimum
deviance residuals are assessed (Table 3).
Identifying Cancer-Related Genes
Among differentially expressed genes, 7-cancer related genes
were obtained including TSLP, IL6, GBP1, CD274, TNFSF13B,
OASL, and pnpla3 after mapping (p < 0.00005) with OMIM
and Cancer Genetics Web database. The references to the role of
these genes in cancer have been shown in Table 4 using PubMed
database.
Cluster and Functional Enrichment
Analysis of DEGs
Clustering analysis has recognized to be helpful to understand
gene function, gene regulation, cellular processes, and subtypes
of cells. The cluster analysis of significantly expressed 7-
cancer related genes was studied with Euclidean distance
(Figure 3). The genetic expression of Shiga effected cell
samples is distinguished from the untreated replicates, indicating
that obvious differences existed between the two groups
(treated and untreated). The analysis showed that 6 down-
regulated and 1 up-regulated genes were significantly enriched.
The total number of enriched terms was calculated with
their significant cutoff parameters (Table 5). The immune
response (p < 1.68E-05), regulation of lymphocyte’s proliferation
(p < 0.001017), T-cell activation (p < 0.002007), cytokine
activity (p < 0.004485), leukocyte homeostasis (p < 0.021097)
and patatin-like phospholipase domain containing-3 were
expressively enriched among dysregulated genes. These gene
products are related to immune response system and signaling
pathways, signaling of chemical mediators and regulation of
a cell defense system (Figure 4A). The dysregulation of these
genes has been found associated with Kaposi sarcoma, cerebral
malformation, familial polyposis, and other clinical phenotypes
(Figure 4B).
Protein-Protein Interaction Network
In PPI network, a total of 215 nodes was retrieved from
STRING and HAPPI databases. In this network, IL6_Human
as a source protein is connected with a number of target
proteins (interactors) (28%) that have been reported in several
cancers followed by the PD1L1_HUMAN (7%) (Figure 5).
Overexpression of PLPL3_HUMAN is associated with 4% of
interactors that are responsible for various types of cancers.
It has been shown that IL6_HUMAN is involved in
the progression of several cancers, extremely responsible
for leukemia, breast cancer and lymphoma (Figure 6).
PD1L1_HUMAN has also been found the connection in a
number of cancer cases, including lung cancer, leukemia,
Hodgkin lymphoma, and head/neck cancers. The observed least
association of OASL_HUMAN is with lymphoma and skin
cancer cases.
De Novo Prediction of Regulatory Motifs
Cancer-related differentially expressed genes were used for over-
representation and de novo analysis. Following transcription
factors (TF) class were found in these DEGs: REL, Stat, TRP-
CLUSTER, and bZIP. They are related to six target matrices in
the Jaspar core profile. Opossum-tool found RELA as a top-
ranked matrix under both the Fisher-score (8.746e−02) and
the z-score (18.14) followed by the STAT1 which satisfied the
thresholds for significant over-representation (Figure 7). This
shows that genes containing conserved RELA, STATI, IRFI, NF-
kappaB, PEND, HLF, REL, CEBPA, DI_2, and NFKB1 binding
sites (Supplementary Figure 2) are indeed over-represented
in cancer-related DEGs and this over-representation can be
recuperated computationally. The rank of parameter settings for
the analysis of oPOSSUM-tool could reflect properties how a
specific TF controls its targets.
DISCUSSION
Monocytes/macrophages are key cellular components of the
human immune system. Upon exposure to Shiga toxins produced
by Shigella dysenteriae serotype 1 and enterohaemorrhagic
Escherichia coli, these cells secrete chemical mediators, which
initiate in?ammation and activate of immune system signals
(Harrison et al., 2005). It has been known that Stx alters the
genetic expression and several signaling pathways triggered by
the toxin modify the expression of several genes in mammalian
cells. The comparative cDNA studies showed that Stx toxins
modulated the transcriptional response of human macrophage-
like THP-1 cells (Leyva-Illades et al., 2010) associated with a
number of abnormalities. In another study, it was observed
that Stxs dysregulated the expression of Gb3/CD77 of lung
carcinoma cell lines (Uchida et al., 1999). Although it is known
that these toxins alter the genetic expression and affect the cellular
division and apoptosis pathway (Elmore, 2007), the underlying
mechanisms and its association with cancer development remain
unclear. The purpose of the current study was to investigate
differentially expressed genes of human THP1 cells in response to
Stxs and the association of these genes with cancer development.
In this study, we found 50 DEGs, and 49 of which were down-
regulated and only a single gene being up-regulated by Stxs.
Among these, 7-genes were mapped with cancer development
that fell into the following functional categories: Immune
response, regulation of lymphocyte’s proliferation, cytokine
activity and patatin-like phospholipase domain containing-3.
These DEGs are linked with important biological pathways
that are related to immune response signaling pathways,
signaling of chemical mediators and regulation of cell defense
system. Dysregulation of these genes can cause Kaposi sarcoma,
familial polyposis, and other clinical phenotypes. These findings
appear different from earlier microarray analyses performed by
Keepers et al. (2006), which revealed Stxs-encoded proteins with
functions related to transcriptional regulation, cell proliferation,
and cell cycle regulation. Cell proliferation, cell morphogenesis,
immune response signaling, anti-apoptosis, and regulation of
cell death are strongly associated with the down-regulated genes,
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FIGURE 4 | Functional enrichment analysis of expressively cancer-related DEGs using FunRich annotation tool (A) Biological pathways analysis (B) clinical
phenotypes for GEGs.
whereas cell cycle process, glycerolipid metabolism, and Patatin-
like phospholipase activity are enriched in the up-regulated
genes. These factors are known to cancer progression (Hunter
and Pines, 1994; DeRisi et al., 1996).
Stxs have been reported to up-regulate the expression
of cytokines and chemokines from human primary blood
monocytes and to transform monocytic cell lines in vitro,
and to affect cytokine expression via several mechanisms,
including the activation of MAPK cascades leading to increased
cytokine gene transcriptional activity and improved translation
initiation efficiency (Harrison et al., 2005). However, in our
analysis, we found that Stxs down-regulated IL6 gene, which
is a potent inducer of the acute phase response and plays
an important role in the final differentiation of B-cells into
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FIGURE 5 | Protein-Protein Interaction network of cancer-related differential expressed genes. Each node represents the protein, while lines indicate the interaction
edges. The association of these source proteins and their interactors (target proteins) in cancers are shown in a bar graph. Blue and red color indicate down and
up-regulated genes, respectively.
Ig-secreting cells responsible for lymphocyte and monocyte
differentiation (Hirano et al., 1986). The downregulation of
IL-6 and other DEGs is associated with highly malignant
mammary carcinomas (Fontanini et al., 1999). Some genes
such as MMP11 (extra-cellular matrix proteins), XRCC1 (DNA
repair), VEGF (regulator of angiogenesis), Cyclin D1 (cell cycle
regulators) and tumor-suppressor genes (Semaphorin 3B, WNT-
5A) have been found as down-regulated genes during lung cancer
progression (Campioni et al., 2008). Recently it has studied that
Stxs elicit a proinflammatory response, including the elevated
production of TNF-α, IL-1β, IL-8, IL-6, and growth-related
oncogene α (Groα) both in vitro and in vivo (Lee et al., 2013).
Furthermore, our analysis reveals that toxin may affect IL6-
expression via a number of mechanisms, including JAK-STAT
cascade, cytosolic DNA-sensing, TNF signaling pathway and
transcriptional misregulation in cancer cells. IL6 is associated
with the progression of multiple cancers, including leukemia,
lymphoma, breast cancer, kidney, and lungs cancer. TNFSF13B
encodes Tumor Necrosis Factor (Ligand) Superfamily, Member
13b, also referred to as B-Cell-Activating Factor. It is important
in the proliferation and differentiation of B-cells that can act
as a transcription factor for its own gene in association with
NF-κB p50 (Yu et al., 2000). Similarly, CD274 is another
gene that is involved in the co-stimulatory signal, essential
for T-cell proliferation and production of IL10 and IFNG.
The dysregulation of this gene inhibits T-cell proliferation and
cytokine production causing a number of cancer including lung,
leukemia, Hodgkin lymphoma, and head/neck cancers (Dong
et al., 1999). We found cytokines and chemokines, including
IL-8, CSF2, GRO-1, GRO-2, and GRO-3, are affected by toxin
exposure (Leyva-Illades et al., 2010). In addition, expression
of TSLP, IL6, GBP1, CD274, TNFSF13B, OASL, and pnpla3
involved in the immune system, cell cycle, T-cell activation and
lymphocyte’s proliferation were also altered in THP1 cells by
toxin treatment. Dysregulation of these genes cause increased
apoptosis, cellular division and cancerous activities (Dong et al.,
1999; Andreoli et al., 2014; Barooei et al., 2015; Hengeveld
and Kersten, 2015; Ibsen et al., 2015; Manda et al., 2015; Ali
et al., 2016). We performed motif enrichment to predict the
transcription factor binding sites and over-represented regions
of these cancer-related genes to better understand the complex
biological mechanism. Several motifs, including RELA, STATI,
IRFI, NF-kappaB, PEND, HLF, REL, CEBPA, DI_2, and NFKB1
were found in the gene set for factors that play critical roles in
modeling required for immune response system, cellular cycles,
chemical mediation and cell growth.
It should be noted that the publicly accessible microarray
dataset studied here were subjected to rigorous statistical
algorithms. Thus, there is a high level of confidence in the list
of differentially expressed genes altered by Stxs. The present
study did not evaluate an independent prognostic factor but
suggest that differentially expressed genes should be evaluated as
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FIGURE 6 | The role of 7 DEGs in various cancers with Absolute Pearson correlation. Red color indicates the maximum involvement of a gene in various cancers and
Blue color represents the least association. This association was curated using OMIM, Cancer Genomic Web, and PubMed databases.
FIGURE 7 | Over-representation of cancer-related DEGs using oPOSSUM with 80% Matrix score.
potential biomarkers for further study to uncover their possible
effects in the diagnosis, treatment, and prognosis of cancers.
CONCLUSION
This study identified differentially expressed genes in human
THP1-monocytic cells upon treatment by bacterial Shiga toxins,
and many of these genes are involved in the pathophysiological
carcinomas. Stxs not only inhibited the protein synthesis
of target cells but even induce the genetic expression and
activate the multiple signaling pathways. Thus, cells treated
with Stxs may lead to progression of multiple cancers. These
findings may provide a valuable framework for developing
diagnostic biomarkers and treatment strategies for cancer.
Further molecular and real-time studies are warranted to
investigate the role of the identified genetic elements in cancer
development.
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